Alzheimer disease and aducanumab: adjusting our approach

Nat Rev Neurol. 2019 Jul;15(7):365-366. doi: 10.1038/s41582-019-0205-1.
No abstract available

MeSH terms

  • Alzheimer Disease / drug therapy*
  • Alzheimer Disease / metabolism
  • Amyloid beta-Peptides / metabolism*
  • Antibodies, Monoclonal, Humanized / therapeutic use*
  • Clinical Trials as Topic
  • Humans
  • Treatment Failure

Substances

  • Amyloid beta-Peptides
  • Antibodies, Monoclonal, Humanized
  • aducanumab